Laurion Capital Management LP Bio N Tech Se Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $2.02 Million - $3.05 Million	-16,359 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$113.32 - $241.49 $431,749 - $920,076	-3,810 Reduced 18.89%	16,359 $3.66 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $58,296 - $81,260	680 Added 3.49%	20,169 $2.2 Million
Q4 2020 Feb 12, 2021	SELL	$72.71 - $129.54 $49,442 - $88,087	-680 Reduced 3.37%	19,489 $1.59 Million
Q1 2020 May 14, 2020	SELL	$28.55 - $92.0 $3.37 Million - $10.9 Million	-118,031 Reduced 85.41%	20,169 $1.18 Million
Q4 2019 Feb 13, 2020	BUY	$12.75 - $36.91 $1.76 Million - $5.1 Million	138,200 New	138,200 $4.68 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.